1- Kakourou T et coll. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol, 2005;53:220-223
2- Jin Y et coll. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med, 2007;356:1216-1225.
3- Gawkrodger DJ et coll. Guideline for the diagnosis and management of vitiligo. Br J Dermatol, 2008 ; 159 : 1051-1076.
4- Khodadadi L et coll. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo. Arch Dermatol Res. 2010;302(8):593-9.
5- Njoo MD et coll. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol, 1998 ; 134 :1532-1540
6- Passeron T et coll. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004;140:1065-9.
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025